Ecto-nucleotidases Activities in the Contents of Ovarian Endometriomas: Potential Biomarkers of Endometriosis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Texidó, Laura ^a   Romero, Claudia ^a   Vidal, August ^a,b   García Valero, José ^c   Fernández Montoli, M Eulalia ^a,b   Baixeras, Núria ^a,b   Condom, Enric ^a,b   Ponce, Jordi ^a,b   García Tejedor, Amparo ^a,b   Martín Satué, Mireia ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; APYRASE; BIOLOGICAL MARKER; ECTOATPASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ECHOGRAPHY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; ENZYME ACTIVITY; EXOSOME; FEMALE; HUMAN; OVARIAN ENDOMETRIOMA; OVARY CYST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; ELECTRON MICROSCOPY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ADULT; BIOLOGICAL MARKERS; ENDOMETRIOSIS; FEMALE; HUMANS; MICROSCOPY, ELECTRON; MIDDLE AGED; OVARIAN CYSTS; YOUNG ADULT;

EID: 84932184171     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/120673     Document Type: Article

References (41)

1. S. E. Bulun, "Endometriosis," New England Journal of Mediane, vol. 360, no. 3, pp. 268-279, 2009.
2. J. A. Maybin, H. O. D. Critchley, and H. N. Jabbour, "Inflammatory pathways in endometrial disorders," Molecular and Cellular Endocrinology, vol. 335, no. 1, pp. 42-51, 2011.
3. K. E. May, S. A. Conduit-Hulbert, J. Villar, S. Kirtley, S. H. Kennedy, and C. M. Becker, "Peripheral biomarkers of endometriosis: a systematic review," Human Reproduction Update, vol. 16, no. 6, pp. 651-674, 2010.
4. D. B. Redwine, "Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease," Fertility and Sterility, vol. 72, no. 2, pp. 310-315, 1999.
5. J. A. Sampson, "Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation," American Journal of Pathology, vol. 3, no. 2, pp. 93-110.43, 1927
6. M. Nishida, K. Watanabe, N. Sato, and Y. Ichikawa, "Malignant transformation of ovarian endometriosis," Gynecologic and Obstetric Investigation, vol. 50, no. 1, pp. 18-25, 2000.
7. L. Muzii, A. Bianchi, C. Crocè, N. Manci, and P. B. Panici, "Laparoscopic excision of ovarian cysts: is the stripping technique atissue-sparingprocedure?" Fertility and Sterility, vol. 77, no. 3, pp. 609-614, 2002.
8. F. Raffi, M. Metwally, and S. Amer, "The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis," Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. 3146-3154, 2012.
9. N. Akamatsu, T. Hirai, H. Masaoka, K. Sekiba, and T. Fujita, "Ultrasonically guided puncture of endometrial cyst-Aspiration of contents and infusion of ethanol," Nihon Sanka Fujinka Gakkai Zasshi, vol. 40, no. 2, pp. 187-191, 1988.
10. E. M. Messalli, G. Cobellis, E. Pecori et al., "Alcohol sclerosis of endometriomas after ultrasound-guided aspiration," Minerva Ginecologica, vol. 55, no. 4, pp. 359-362, 2003.
11. J. D. Fisch and G. Sher, "Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization," Fertility and Sterility, vol. 82, no. 2, pp. 437-441, 2004.
12. C. Yazbeck, P. Madelenat, J. P. Ayel et al., "Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation," Reproductive BioMedicine Online, vol. 19, no. 1, pp. 121-125, 2009.
13. G. Gatta, V. Parlato, G. Di Grezia et al., "Ultrasound-guided aspiration and ethanol sclerotherapy for treating endometrial cysts," Radiologia Medica, vol. 115, no. 8, pp. 1330-1339, 2010.
14. T. Koike, H. Minakami, M. Motoyama, S. Ogawa, H. Fujiwara, and I. Sato, "Reproductive performance after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometriotic cysts," European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 105, no. 1, pp. 39-43, 2002.
15. K. Yamaguchi, M. Mandai, S. Toyokuni et al., "Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress," Clinical Cancer Research, vol. 14, no. 1, pp. 32-40, 2008.
16. E. G. Lo Turco, F. B. Cordeiro, P. H. de Carvalho Lopes et al., "Proteomic analysis of follicular fluid from women with and without endometriosis: new therapeutic targets and biomarkers," Molecular Reproduction and Development, vol. 80, no. 6, pp. 441-450, 2013.
17. H. K. Eltzschig, M. V. Sitkovsky, and S. C. Robson, "Purinergic signaling during inflammation," The New England Journal of Medicine, vol. 367, no. 24, pp. 2322-2333, 2012.
18. W. G. Junger, "Immune cell regulation by autocrine purinergic signalling," Nature Reviews Immunology, vol. 11, no. 3, pp. 201-212, 2011.
19. F. Kukulski, S. A. Lévesque, and J. Sévigny, "Impact of ectoen-zymes on p2 and pl receptor signaling," Advances in Pharmacology, vol. 61, pp. 263-299, 2011.
20. G. G. Yegutkin, "Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade," Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1783, no. 5, pp. 673-694, 2008.
21. M. Martín-Satué, E. G. Lavoie, M. Fausther et al., "High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract," Histochemistry and Cell Biology, vol. 133, no. 6, pp. 659-668, 2010.
22. M. Fausther, J. Lecka, E. Soliman et al., "Coexpression of ecto-5°-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver," The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 302, no. 4, pp. 447-459, 2012.
23. L. Antonioli, P. Pacher, E. S. Vizi, and G. Haskó, "CD39 and CD73 in immunity and inflammation," Trends in Molecular Medicine, vol. 19, no. 6, pp. 355-367, 2013.
24. E. Aliagas, B. Torrejón-Escribano, E. G. Lavoie et al., "Changes in expression and activity levels of ecto-5/-nucleotidase/CD73 along the mouse female estrous cycle," Acta Physiologica, vol. 199, no. 2, pp. 191-197, 2010.
25. E. Aliagas, A. Vidal, B. Torrejón-Escribano et al., "Ectonucleotidases distribution in human cyclic and postmenopausic endometrium," Purinergic Signalling, vol. 9, no. 2, pp. 227-237, 2013.
26. E. Aliagas, A. Vidal, L. Texido, J. Ponce, E. Condom, and M. Martin-Satue, "High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors," Mediators of Inflammation, vol. 2014, Article ID 509027, 8 pages, 2014.
27. C. Théry, L. Zitvogel, and S. Amigorena, "Exosomes: composition, biogenesis and function," Nature Reviews Immunology, vol. 2, no. 8, pp. 569-579, 2002.
28. C. Gutiérrez-Vázquez, C. Villarroya-Beltri, M. Mittelbrunn, and F. Sanchez-Madrid, "Transfer of extracellular vesicles during immune cell-cell interactions," Immunological Reviews, vol. 251, no. 1, pp. 125-142, 2013.
29. A. Clayton, S. Al-Taei, J. Webber, M. D. Mason, and Z. Tabi, "Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production," Journal of Immunology, vol. 187, no. 2, pp. 676-683, 2011.
30. + T cells contributes to their regulatory function," European Journal of Immunology, vol. 43, no. 9, pp. 2430-2440, 2013.
31. P. J. Schuier, Z. Saze, C. S. Hong et al, "Human CD4(+) CD39(+) regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73(+) exosomes or CD73(+) cells," Clinical & Experimental Immunology, vol. 177, no. 2, pp. 531-543, 2014.
32. D. Timmerman, L. Valentin, T. H. Bourne, W. P. Collins, H. Verreist, and I. Vergote, "Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group," Ultrasound in Obstetrics & Gynecology, vol. 16, no. 5, pp. 500-505, 2000.
33. M. M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding," Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
34. P. A. Lanzetta, L. J. Alvarez, P. S. Reinach, and O. A. Candia, "An improved assay for nanomole amounts of inorganic phosphate," Analytical Biochemistry, vol. 100, no. 1, pp. 95-97, 1979.
35. C. Théry, S. Amigorena, G. Raposo, and A. Clayton, "Isolation and characterization of exosomes from cell culture supernatants and biological fluids," Current Protocols in Cell Biology, vol. 3, 2006.
36. G. G. Yegutkin, S. S. Samburski, S. Jalkanen, and I. Novak, "ATP-consuming and ATP-generating enzymes secreted by pancreas," The Journal of Biological Chemistry, vol. 281, no. 40, pp. 29441-29447, 2006.
37. G. G. Yegutkin, B. Wieringa, S. C. Robson, and S. Jalkanen, "Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTP-Dasel/CD39 activities," The FASEB Journal, vol. 26, no. 9, pp. 3875-3883, 2012.
38. M. R. Schetinger, V. M. Morsch, C. D. Bonan, and A. T. S. Wyse, "NTPDase and 5°-nucleotidase activities in physiological and disease conditions: new perspectives for human health," Biofactors, vol. 31, no. 2, pp. 77-98, 2007
39. K. R. Park, T. Inoue, M. Ueda et al., "CD9 is expressed on human endometrial epithelial cells in association with integrins α6, α3 and β1," Molecular Human Reproduction, vol. 6, no. 3, pp. 252-257, 2000.
40. Y. H. Ng, S. Rome, A. Jalabert et al., "Endometrial exo-somes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation," PLoS ONE, vol. 8, no. 3, Article ID e58502, 2013.
41. K. L. Bruner-Tran, J. L. Herington, A. J. Duleba, H. S. Taylor, and K. G. Osteen, "Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology," Minerva Ginecologica, vol. 65, no. 2, pp. 199-213, 2013.